Visual and neurological disturbances after injection of sclerosing foam;Troubles visuels et neurologiques après injection de mousse sclérosante

Phlebologie - Annales Vasculaires

Volumn 62, Issue 2, 2009, Pages 26-30

  Gillet, J L ^a  

^a NONE   (France)

Author keywords

Cerebral accident; Echosclerotherapy; Sclerosing foam; Visual disturbance

Indexed keywords

EID: 77958014498     PISSN: 00318280     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Ceulen RP, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med. 2008;358:1525-6
2. Blin E. Imagerie échocardiographique après injection de mousse sclérosante. Phlébologie 2009;62:19-22
3. D Wright et al. A single center pilot study of polidocanol endovenous microfoam (PEM) treatment to evaluate presence and durability of gas emboli using echocardiography (abstract). 22sd annual Congress of the American College of Phlebology, November 2008, Marco Island, FI.
4. Morrison N. Foam sclerotherapy, how to improve results and side effects. Phlebologie 2008;37:211-220.
5. Gibson KD et al. Proprietary polidocanolendovenousmicrofoam (PEM) bubble embolization does not cause cerebral injury (abstract). 22sd annual Congress of the American College of Phlebology, November 2008, Marco Island, FI.
6. Raymond-Martimbeau P. Detection of patent foramen ovale before foam sclerotherapy. (Abstract). 21st annual Congress of the American College of Phlebology, November 8-11 2007, Tucson, Az.
7. Neuhardt D et al. Emboli detection in middle cerebral artery concurrent with treatment of lower extremity superficial venous insufficiency with foam sclerotherapy (abstract). 22sd annual Congress of the American College of Phlebology, November 2008, Marco Island, FI.
8. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. BJS 2007:94;925-936
9. Gillet JL et All. Effets secondaires et complications de Péchosdérothérapie à la mousse des troncs saphènes: l'étude Cesmous. Phlébologie 2008;3:288-9.
10. Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lauseker M et al. Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009;24:131-138.
11. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and Mid-term Complications of Sclerotherapy. Report of a Prospective Multi-Centric Registry of 12, 173 Sclerotherapy Sessions. Dermatol Surg 2005;31:123-8.
12. Guex JJ, Allaert FA, Gillet JL, Chleir F. Incidence des complications de la sdérothérapie: analyse d'un registre multicentrique réalise chez 22 phlébologues pendant 12 semaines (12 173 séances). Phlébologie 2005;58:189-95.
13. Gillet JL, Guex JJ, Allaert FA, Chleir F. Incidence des complications de la sclérothérapie à la mousse: résultats de l'étude de la Société Française de Phlébologie. Phlébologie 2005;58:349-351.
14. Benigni JP, Ratinahirana H. Mousse de Polidocanol et migraine à aura. Phlébologie 2003;56:289-91.
15. Donnet A. Migraine et sclérothérapie à la mousse: le point de vue du neurologue. Phlébologie 2008;61:77-9.
16. Coleridge Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vase Endovasc Surg 2006;32:577-83.
17. Künzlberger B, Pieck C, Altmeyer P, Stücker M. Migraine ophtalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol. Dermatol Surg. 2006;32:1410-3
18. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-404.
19. Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory [review]. Brain 1994;117:199-210.
20. Lassen NA, Friberg L. Cerebral blood flow measurement by xenon 133 using the intra-arterial injection method or inhalation combined with SPECT in migraine research. In: Olesen J, editor. Migraine and other headaches. The vascular mechanisms. New York: Raven Press; 1991: p 5-13.
21. Whitty CWM. Familial hemiplegic migraine. In: Vinken PJ, Bruyn GW, Klawans HL, Clifford Rose F, editors. Headache, handbook of clinical neurology, Vol. 48. Amsterdam: Elsevier; 1986. p. 141-53.
22. Dichgans M, Mayer M, Uttner I, Brüning R, Muller-Hocker J, Rungger G, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998;44:731-9.
23. Dreier JP, Kleeberg J, Petzold G, Priller J, Windmüller O, Orzechowski HD, Lindauer U, Heinemann U, Einhäupl KM, Dirnagl U. Endothelin-i potently induces Leäo's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain 2002;125:102-12;125:102-12.
24. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, Salles-Cunha SX. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vase Surg. 2008;47:830-6.
25. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vase Surg. 2006;43:162-4.
26. Bush RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008;23:189-192.
27. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003;107:5-9.
28. Hanisch F, Müller T, Krivocuca M, Winterholler M. Stroke following variceal sclerotherapy. Eur J Med Res 2004;9:282-4.
29. Breu FX, Guggenbichler S, Wollmann JC; Second European Consensus Meeting on Foam Sclerotherapy. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meetingon Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa. 2008;37:90-5.
30. Morrison N, Cavezzi A, Bergan J, Partsch H. Letter to the editor regarding "Stroke after varicose vein foam injection sclerotherapy". J Vase Surg 2007;44:224-5.
31. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139:1409-16.
32. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002;17:13-8.
33. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation ofthe efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-5.
34. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplexguided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg. 2004;30:718-22.
35. Schadeck M. Sclérose de la petite veine saphène: comment éviter les mauvais résultats? Phlébologie 2004;57:165-69.
36. Ceulen RP, Bullens-Goessens Yl, Pi-VAN DE Venne SJ, Nelemans PJ, Veraart JC, Sommer A. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with i-year followup. Dermatol Surg. 2007 Mar; 33:276-81
37. Hamel-Desnos C, Ouvry P, Benigni JP, Boitelle G, Schadeck M, Desnos P, Allaert FA. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomized, double-blind trial with 2 year-follow-up. "The 3/1 Study". Eur J Vase Endovasc Surg. 2007;34:723-9
38. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardized polidocanol foam (ESAF): a randomized controlled multicentre clinical trial. Eur J Vase Endovasc Surg. 2008 Feb; 35:238-45.
39. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C. Efficacy of Polidocanol Foam versus Liquid in Sclerotherapy of the Great Saphenous Vein: A Multicentre Randomized Controlled Trial with a Two-year Follow-up. EJVES 2008;36:366-70.
40. Guex JJ, Hamel-Desnos C, Gillet JL, Chleir F, Perrin M. Sclérothérapie des varices par mousse échoguidée: techniques de mise en œuvre, indications, résultats publiés. Phlébologie 2008;61:261-70.
41. Gachet G, Spini L. Référentiel sur le traitement endovasculaire des varices par injections échoguidées de mousses fibrosantes: le consensus d'experts de Grenoble (version 2007). Phlébologie 2008;61:196-206.
42. Hill D, Hamilton R, Fung T. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein. J Vase Surg 2008;48:934-9.